surmount-1 trial tirzepatide obesity without diabetes weight loss after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 GLP-1-based combination strategies for weight

2024;16(756):eadk0330

Patients with genetic predispositions toward stronger GLP-1R sensitivity may achieve meaningful results with semaglutide, making the lower cost genuinely cost-effective for their profile

I numeri parlano chiaro: nel 2024 le vendite dei farmaci GLP-1 come la semaglutide (Ozempic, Wegovy) e la tirzepatide (commercializzate come Mounjaro) hanno registrato un balzo del 78,7% nella vendita con ricetta bianca

Int J Obes 34(3):407419

(1) In fact, semaglutide has been said to be 94% similar to the GLP hormones in the body

Theres a lot of misinformation out there and we believe in realistic, sustainable results, not hype